Ultrasensitive circulating tumor DNA analysis improves detection of molecular residual disease in locally advanced esophageal cancer

循环肿瘤DNA 食管癌 医学 生物标志物 微小残留病 内科学 癌症 疾病 突变 病理 肿瘤科 液体活检 循环肿瘤细胞 胃肠病学 检出限 DNA测序 DNA 癌症研究 癌 进行性疾病 预测值
作者
Justin Rhoades,Anuj Kishor Patel,Kan Xiong,Timothy Blewett,Rachel Li,Laurel Walsh,Andjela Crnjac,James Ratty,Oliver Limbo,Alison M. Hannigan,Joshua Remland,Lauren K. Brais,Pia Jain,Sainetra Sridhar,Katie Gilligan,Matthew L. Carnes,Kee‐Young Shin,Paul J. Catalano,Daniel C. Wiener,David James Papke
出处
期刊:Clinical Cancer Research [American Association for Cancer Research]
标识
DOI:10.1158/1078-0432.ccr-25-4852
摘要

PURPOSE: Circulating tumor DNA (ctDNA) could be a powerful prognostic biomarker for patients with locally advanced esophageal cancer but higher sensitivity is needed. An ultrasensitive test could enable improved treatment decision-making by accurately identifying patients with residual disease. EXPERIMENTAL DESIGN: 331 plasma samples from 36 patients were collected both preoperatively and postoperatively. We applied MAESTRO-Pool (Minor Allele Enriched Sequencing Through Recognition Oligonucleotides) of the Broad Institute and the Oncodetect® V2 test of Exact Sciences, two MAESTRO-based, ultrasensitive, tumor-informed, mutation enrichment sequencing tests, to all samples. RESULTS: With the Oncodetect V2 test, we found 9 of 14 patients (64%) with recurrence and postoperative plasma available tested ctDNA-positive at their first postoperative sample and all 14 patients tested ctDNA-positive for at least one postoperative sample prior to recurrence. ctDNA was detected below the limit of detection for first-generation assays in 59% of all samples in which we detected ctDNA. By tracking a median of 2.1-fold more mutations per patient (up to 5,000 total mutations per patient), the Oncodetect V2 test showed highly concordant results (98.9% positive percent agreement), improved ctDNA detection, and longer lead times to recurrence as compared to MAESTRO-Pool. CONCLUSION: ctDNA detection after curative-intent therapy for locally advanced esophageal cancer had strong positive and negative predictive values for recurrence. Given the low ctDNA levels observed, and that all patients with recurrence were eventually ctDNA-positive, ctDNA testing in esophageal cancer may benefit from ultrasensitive tests that detect part-per-million levels of ctDNA.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
安详的梦秋完成签到,获得积分20
刚刚
有点礼貌但不多完成签到 ,获得积分20
刚刚
刚刚
xing_xing的应助被QQ糖采纳,获得20
1秒前
1秒前
2秒前
456发布了新的文献求助10
3秒前
3秒前
Hello的应助被杰斯顿采纳,获得10
4秒前
5秒前
Dr.XX完成签到,获得积分10
5秒前
5秒前
欣喜成仁完成签到,获得积分10
5秒前
ywl发布了新的文献求助10
5秒前
今后的应助被无限的尔安采纳,获得10
6秒前
Kyone完成签到,获得积分10
6秒前
chen完成签到,获得积分10
6秒前
看到就去签到完成签到,获得积分10
7秒前
molihuakai的应助被盒子采纳,获得10
7秒前
RR发布了新的文献求助10
7秒前
molihuakai的应助被勤奋乌龟采纳,获得10
8秒前
科研通AI6.3的应助被杨媛采纳,获得10
8秒前
9秒前
9秒前
9秒前
传奇3的应助被阔达的悟空采纳,获得10
9秒前
9秒前
9秒前
benmao_mogu发布了新的文献求助10
10秒前
10秒前
思源的应助被高高冷风采纳,获得10
10秒前
10秒前
diedeline发布了新的文献求助10
11秒前
杰斯顿完成签到,获得积分10
11秒前
molihuakai的应助被单薄翠绿采纳,获得10
11秒前
汉堡包的应助被单薄翠绿采纳,获得10
12秒前
路人甲完成签到 ,获得积分10
12秒前
路人甲完成签到 ,获得积分10
12秒前
Quj完成签到,获得积分10
12秒前
整齐的白山完成签到,获得积分10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178341
求助须知:如何正确求助?哪些是违规求助? 9569073
关于积分的说明 21802629
捐赠科研通 7773188
什么是DOI,文献DOI怎么找? 3432780
关于科研通互助平台的介绍 2556770
邀请新用户注册赠送积分活动 2478298